Nov 8, 2024, 04:47
ICIs for patients with metastatic triple-negative Inflammatory Breast Cancer
Dana-Farber’s Breast Oncology Center shared a post on X:
“This just published international cohort study called INCORPORATE looked at immune checkpoint inhibitors for patients with metastatic triple-negative Inflammatory Breast Cancer.
Read it here for free until December 20.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 30, 2025, 06:50
May 30, 2025, 06:43
May 30, 2025, 06:25
May 30, 2025, 06:09